Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

Emalex Biosciences met primary and secondary endpoints in its Phase 3 registrational trial of ecopipam for patients with ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Since Baylen Out Loud premiered on TLC in January 2025, Tourette syndrome advocate Baylen Dupree has gained even more social ...

Baylen Out Loud star Baylen Dupree has considered undergoing deep brain stimulation as a treatment for her symptoms of ...

Baylen Dupree has support from her fiancé, Colin Dooley, as she navigates life with Tourette syndrome. After they found love ...

Chicago, USA-based Emalex Biosciences announced positive top-line data from its Phase III registrational study of ecopipam, a ...

Ontario’s police watchdog has concluded a Greater Sudbury Police officer did nothing wrong after he handcuffed a man who ...

Baylen Dupree was interviewed on the 'Not Skinny But Not Fat' podcast on Feb. 19 and revealed she doesn't get tics when she's ...